Annual Report FY25 filed during CIRP, zero revenue, resolution plan approved

Going ConcernPat NegativeRevenue DeclineResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.0%Reaction day

₹7.52

prior close

₹7.67

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.3%+2.3% vs market

Commodity Chemicals peers, median of 55sector-0.1%+2.1% vs sector

On the reaction day the stock moved 2.3 pts more than Nifty Microcap 250 and 2.1 pts more than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.0-0.3+2.3-0.1+2.1

Next day

+4.0+0.8+3.2-0.6+4.6

+6.0+0.9+5.1-0.5+6.5

+8.0+1.8+6.2-0.1+8.1

+10.1+1.5+8.7+0.0+10.1

+12.2+1.7+10.6-0.1+12.3

+16.4-1.1+17.4-1.3+17.7

15d

+28.1+1.0+27.0+0.2+27.9

+11.6+0.4+11.2+0.6+11.0

-26.9+6.4-33.2+1.1-28.0

-50.0+5.5-55.5+3.4-53.4

UpDownMarket · Nifty Microcap 250Sector · Commodity Chemicals peers, median of 55Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Kobo Biotech filed FY2024-25 annual report while under corporate insolvency resolution process (CIRP) since August 2024. NCLT admitted petition filed by JM Financial Asset Reconstruction Company. Board is suspended, Solapur plant remains shut. Revenue from operations is nil. Total income at Rs. 152 thousand. Loss after tax widened to Rs. 52.30 crore from Rs. 49.29 crore. NCLT approved a resolution plan from Beaufond Industries in May 2026, awaiting implementation. AGM on July 24, 2026 via video conference.

Likely market impact

Company is insolvent with zero operations and widening losses. Resolution plan approval may enable revival, but existing shareholders likely face dilution or loss.